Nectar Lifesciences Ltd

NECLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹543 cr, stock is ranked 1,210
High RiskStock is 3.70x as volatile as Nifty
25.351.10 (+4.54%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹543 cr, stock is ranked 1,210
High RiskStock is 3.70x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-7.42
PB RatioPB Ratio
0.51
Dividend YieldDiv. Yield
Sector PESector PE
30.35
Sector PBSector PB
4.67
Sector Div YldSctr Div Yld
0.91%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020211.882.792.371.550.050.050.03-0.07
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Resignation 
Announced OnMay 9, 2022

Nectar Lifesciences Limited has informed the Exchange about resignation of Guljit Sethi as Independent Director of the company w.e.f. 09-May-2022. The relevant disclosures are attached herewith. | Download

Nectar Lifesciences Limited has informed the Exchange about resignation of Guljit Sethi as Independent Director of the company w.e.f. 09-May-2022. The relevant disclosures are attached herewith. | Download

Resignation 
Announced OnMay 6, 2022

Nectar Lifesciences Limited has informed the Exchange about resignation of Vivek Sett as Non Executive - Non Independent Director (Nominee Director) of the company w.e.f. 06-May-2022 | Download

Nectar Lifesciences Limited has informed the Exchange about resignation of Vivek Sett as Non Executive - Non Independent Director (Nominee Director) of the company w.e.f. 06-May-2022 | Download

Cash Dividend 
Ex. DateSep 11, 2020

Final • Div/Share: ₹ 0.05

See all events